DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Human Chorionic Gonadotropin Supplementation Prior to In-vitro Fertilization Treatment in Poor Responders

Information source: Hadassah Medical Organization
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Infertility

Intervention: Ovitrelle (Drug)

Phase: N/A

Status: Not yet recruiting

Sponsored by: Hadassah Medical Organization

Official(s) and/or principal investigator(s):
Mushira Aboo Dia, MD, Principal Investigator, Affiliation: Hadassah Medical Center

Overall contact:
Mushira Aboo Dia, , MD, Email: mushiraa@gmail.com

Summary

In an era of delayed fertility plans, there is increasing need for fertility treatment in older women with poor response. Human chorionic gonadotropin (hCG) supplementation prior to treatment, as a thecal stimulant, may improve folliculogenesis and ovarian response.

Clinical Details

Study design: Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment

Primary outcome: number of oocytes retrieved

Eligibility

Minimum age: 40 Years. Maximum age: 45 Years. Gender(s): Female.

Criteria:

Inclusion Criteria:

- women >39 years on IVF treatment

Exclusion Criteria:

- polycystic ovary syndrome

- Any allergy to injection of human chorionic gonadotropin before

Locations and Contacts

Mushira Aboo Dia, , MD, Email: mushiraa@gmail.com

Hadassah Medical Center, Jerusalem, Israel; Not yet recruiting
Arik Tzukert, DMD, Phone: 0097226776095, Email: arik@hadassah.org.il
Mushira Aboo Dia, MD, Phone: 0097226776425, Email: mushiraa@gmail.com
Additional Information

Starting date: April 2011
Last updated: March 1, 2011

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017